BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9459279)

  • 1. Development of male contraceptive vaccine--a perspective.
    Moudgal NR; Jeyakumar M; Krishnamurthy HN; Sridhar S; Krishnamurthy H; Martin F
    Hum Reprod Update; 1997; 3(4):335-46. PubMed ID: 9459279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-LHRH and anti-pituitary gonadotropin vaccines: their development and clinical applications.
    Thau R
    Scand J Immunol Suppl; 1992; 11():127-30. PubMed ID: 1514027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of immuno-contraceptive vaccines for population control. I. Hormonal immunocontraception.
    Gupta SK; Koothan PT
    Arch Immunol Ther Exp (Warsz); 1990; 38(1-2):47-60. PubMed ID: 2126920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibition of the biological activity of follicle-stimulating hormone by anti-peptide antisera representing the human follicle-stimulating hormone beta subunit sequence 33-53.
    Westhoff WE; Slootstra JW; Puijk WC; van Leeuwen L; Schaaper WM; Oonk HB; Meloen RH
    Biol Reprod; 1997 Feb; 56(2):460-8. PubMed ID: 9116147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of epitopes on follicle-stimulating hormone and FSH-antiserum-induced suppression of bioactivity of follicle-stimulating hormone and luteinizing hormone.
    Westhoff WE; Slootstra JW; Puijk WC; Kuperus D; Flinterman JF; Schaaper WM; Oonk HB; Meloen RH
    J Reprod Immunol; 1996 May; 30(2-3):133-49. PubMed ID: 8816329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
    Lemarchand-BĂ©raud T; Reymond M; Rappoport G; Magrini G; Gomez J
    Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of active and passive immunization with luteinizing hormone-releasing hormone on serum luteinizing hormone and follicle-stimulating hormone levels and the ultrastructure of the pituitary gonadotrophs in castrated male rats.
    Arimura A; Shino M; de la Cruz KG; Rennels EG; Schally AV
    Endocrinology; 1976 Jul; 99(1):291-303. PubMed ID: 780100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fertility regulating and immunotherapeutic vaccines reaching human trials stage.
    Talwar GP
    Hum Reprod Update; 1997; 3(4):301-10. PubMed ID: 9459276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraceptive vaccines: success, status, and future perspective.
    Naz RK
    Am J Reprod Immunol; 2011 Jul; 66(1):2-4. PubMed ID: 21645164
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in contraceptive vaccine development: a mini-review.
    Naz RK; Gupta SK; Gupta JC; Vyas HK; Talwar AG
    Hum Reprod; 2005 Dec; 20(12):3271-83. PubMed ID: 16113040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines for control of fertility.
    Talwar GP; Singh O; Pal R; Chatterjee N; Suri AK; Shaha C
    Indian J Exp Biol; 1992 Nov; 30(11):947-50. PubMed ID: 1293038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term contraceptive efficacy of vaccine of ovine follicle-stimulating hormone in male bonnet monkeys (Macaca radiata).
    Moudgal NR; Ravindranath N; Murthy GS; Dighe RR; Aravindan GR; Martin F
    J Reprod Fertil; 1992 Sep; 96(1):91-102. PubMed ID: 1432977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsiveness of human male volunteers to immunization with ovine follicle stimulating hormone vaccine: results of a pilot study.
    Moudgal NR; Murthy GS; Prasanna Kumar KM; Martin F; Suresh R; Medhamurthy R; Patil S; Sehgal S; Saxena BN
    Hum Reprod; 1997 Mar; 12(3):457-63. PubMed ID: 9130740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsatile follicle-stimulating hormone secretion is independent of luteinizing hormone-releasing hormone (LHRH): pulsatile replacement of LHRH bioactivity in LHRH-immunoneutralized rats.
    Culler MD; Negro-Vilar A
    Endocrinology; 1987 May; 120(5):2011-21. PubMed ID: 2436893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How far from a hormone-based contraceptive vaccine?
    Delves PJ
    J Reprod Immunol; 2004 Jun; 62(1-2):69-78. PubMed ID: 15288183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of injection of anti-luteinizing hormone (LH)-releasing hormone serum and anti-gonadotropin-releasing hormone-associated peptide serum into neonatal rats on LH and follicle-stimulating hormone cells.
    Blake CA; Campbell GT; Mascagni F; Culler MD; Negro-Vilar A
    Biol Reprod; 1993 Nov; 49(5):965-71. PubMed ID: 8286592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive immunization for immunocontraception: lessons learned from infectious diseases.
    Naz RK; Rajesh C
    Front Biosci; 2004 Sep; 9():2457-65. PubMed ID: 15353298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in the development of anti-LHRH vaccine.
    Ladd A
    Am J Reprod Immunol; 1993 Apr; 29(3):189-94. PubMed ID: 8373528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.